Population pharmacokinetics and exposure‐response analyses of teduglutide in adult and pediatric patients with short bowel syndrome

Teduglutide is a recombinant analog of human glucagon‐like peptide‐2 that regulates the functional and structural integrity of the cells lining the gastrointestinal tract. Teduglutide is approved for the treatment of patients with short bowel syndrome (SBS) who are dependent on parenteral support (P...

Descripción completa

Detalles Bibliográficos
Autores principales: Marier, Jean‐Francois, Jomphe, Claudia, Peyret, Thomas, Wang, Yi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8604237/
https://www.ncbi.nlm.nih.gov/pubmed/34402197
http://dx.doi.org/10.1111/cts.13117

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8604237/
https://www.ncbi.nlm.nih.gov/pubmed/34402197
http://dx.doi.org/10.1111/cts.13117

Ejemplares similares